Therapeutic Asset Ratings
461 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
pf-07265028
Urothelial Carcinoma
Pfizer
P1
CC
(41)
pf-07329640
Urothelial Carcinoma
Pfizer
P1
CC
(41)
pf-07799544
Thyroid Cancer
Pfizer
P1
CC
(41)
pf-07820435
Ovarian Carcinoma
Pfizer
P1
CC
(41)
pf-07826390
Ovarian Carcinoma
Pfizer
P1
CC
(41)
pf-08032562
Colorectal Adenocarcinoma
Pfizer
P1
CC
(41)
pf-08046031
Melanoma
Pfizer
P1
CC
(41)
pf-08046032
Classic Hodgkin Lymphoma
Pfizer
P1
CC
(41)
pf-08046033
Cutaneous Melanoma
Pfizer
P1
CC
(41)
pf-08046037
Melanoma
Pfizer
P1
CC
(41)
pf-08046876
Advanced/Metastatic Solid Tumors
Pfizer
P1
CC
(41)
pf-08046876
Non-Small Cell Lung Carcinoma
Pfizer
P1
CC
(41)
Atirmociclib
Neoplasm
Pfizer
P1/2
CC
(41)
PF-07104091
Neoplasm
Pfizer
P1/2
CC
(41)
Sasanlimab
Non-Small Cell Lung Carcinoma
Pfizer
P2/3
CC
(41)
FLURBIPROFEN
Sickle Cell Disease
Pfizer
P1
CC
(40)
FUROSEMIDE
Sickle Cell Disease
Pfizer
P1
CC
(40)
Maplirpacept
Plasma Cell Myeloma
Pfizer
P1
CC
(40)
Omeprazole
Sickle Cell Disease
Pfizer
P1
CC
(40)
REPAGLINIDE
Sickle Cell Disease
Pfizer
P1
CC
(40)
Rosuvastatin
Sickle Cell Disease
Pfizer
P1
CC
(40)
Wellbutrin
Sickle Cell Disease
Pfizer
P1
CC
(40)
Maplirpacept
Ovarian Carcinoma
Pfizer
P1/2
CC
(40)
Maplirpacept
Primary Peritoneal Carcinoma
Pfizer
P1/2
CC
(40)
Sasanlimab
Neoplasm
Pfizer
P2
C
(39)
Showing 326 to 350 of 461 assets
Previous
Page 14 of 19
Next
